Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-06 Sale | 2023-03-08 4:16 pm | JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks | 1,062 | $154.66 | $164,199 | 9,215 (Direct) | View |
| 2022-12-13 Sale | 2022-12-15 4:34 pm | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 14,781 | $179.6 | $2,654,661 | 37,800 (Indirect Direct) | View |
| 2022-11-30 Sale | 2022-12-02 4:32 pm | JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech | 73,323 | $175.47 | $12,865,801 | 44,808 (Indirect Direct) | View |
| 2022-11-22 Sale | 2022-11-23 4:44 pm | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | 76,923 | $176.78 | $13,598,402 | 126,456 (Direct) | View |
| 2022-11-18 Sale | 2022-11-21 4:33 pm | JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO | 16,928 | $175 | $2,962,400 | 16,178 (Indirect Direct) | View |
| 2022-11-09 Sale | 2022-11-10 4:47 pm | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer | 16,410 | $173.42 | $2,845,773 | 71,644 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-07 Option Award | 2023-03-09 5:41 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Washington A. Eugene Director | 201 | $155.16 | 28,569 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 5:41 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 234 | $155.16 | 6,431 (Direct) | View |
Ownership | 2023-02-22 12:59 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Johnson Paula A Director | 0 | $0 | 100 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:25 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 114,365 | $0 | 146,057 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:25 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 8,578 | $162.01 | 146,057 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:25 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 45,109 | $0 | 113,004 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:25 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 4,891 | $162.01 | 113,004 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:25 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | 89,962 | $0 | 208,130 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:25 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | 10,569 | $162.01 | 208,130 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:25 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks | 26,760 | $0 | 33,809 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:25 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks | 918 | $162.01 | 33,809 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:25 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health | 73,682 | $0 | 125,887 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:25 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health | 6,430 | $162.01 | 125,887 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:24 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech | 82,993 | $0 | 122,847 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:24 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech | 7,158 | $162.01 | 122,847 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:24 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 53,506 | $0 | 131,613 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:24 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 4,586 | $162.01 | 131,613 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:24 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 61,131 | $0 | 171,359 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:24 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 5,765 | $162.01 | 171,359 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:24 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 213,978 | $0 | 499,881 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:24 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 13,599 | $162.01 | 499,881 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:24 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 10,144 | $0 | 26,320 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:24 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 397 | $162.01 | 26,320 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:24 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 36,825 | $0 | 39,754 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:24 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 924 | $162.01 | 39,754 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 7:24 pm | N/A 2033-02-13 | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 25,468 | $0 | 40,690 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 7:24 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 1,440 | $162.01 | 40,690 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:37 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 5,220 | $0 | 299,502 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:37 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 2,267 | $162.08 | 299,502 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:37 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 1,807 | $0 | 72,786 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:37 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 667 | $162.08 | 72,786 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:36 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 3,449 | $0 | 40,270 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 979 | $162.08 | 40,270 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:36 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | 3,570 | $0 | 128,737 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | 1,289 | $162.08 | 128,737 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:36 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech | 2,999 | $0 | 47,012 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech | 823 | $162.08 | 47,012 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:35 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 1,022 | $0 | 3,853 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:35 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 380 | $162.08 | 3,853 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:35 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 3,856 | $0 | 82,693 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:35 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Hait William See Remarks | 1,399 | $162.08 | 82,693 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:35 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health | 2,285 | $0 | 58,635 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:35 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health | 826 | $162.08 | 58,635 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:35 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 581 | $0 | 16,573 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:35 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 191 | $162.08 | 16,573 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:35 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 1,592 | $0 | 16,662 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:35 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 597 | $162.08 | 16,662 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:35 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 2,078 | $0 | 115,993 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:35 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 761 | $162.08 | 115,993 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 4:34 pm | 2023-02-10 N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks | 1,291 | $0 | 29,296 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:34 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks | 388 | $162.08 | 29,296 (Direct) | View |
| 2022-02-14 Option Award | 2023-02-14 4:34 pm | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks | 1,961 | $0 | 29,296 (Direct) | View |
| 2022-02-14 Option Award | 2023-02-14 4:34 pm | 2025-02-14 2032-02-14 | JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks | 19,368 | $165.89 | 29,296 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-18 4:39 pm | 2016-01-17 2023-01-13 | JOHNSON & JOHNSON | JNJ | Gorsky Alex Director | 547,692 | $72.54 | 768,336 (Direct) | View |
| 2023-01-17 Tax Withholding | 2023-01-18 4:39 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Gorsky Alex Director | 366,610 | $173.43 | 768,336 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-18 4:39 pm | 2016-01-17 2023-01-13 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 148,538 | $72.54 | 296,541 (Direct) | View |
| 2023-01-17 Tax Withholding | 2023-01-18 4:39 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 98,795 | $173.43 | 296,541 (Direct) | View |
| 2022-12-13 Exercise | 2022-12-15 4:34 pm | 2016-01-17 2023-01-13 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 14,781 | $0 | 37,800 (Direct) | View |
| 2022-12-13 Exercise | 2022-12-15 4:34 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 1,855 | $72.54 | 37,800 (Direct) | View |
| 2022-04-20 Gift | 2022-12-15 4:34 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 46 | $0 | 37,800 (Direct) | View |
| 2022-12-13 Exercise | 2022-12-15 4:34 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 12,926 | $90.44 | 37,800 (Direct) | View |
| 2022-12-06 Option Award | 2022-12-08 4:45 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director | 241 | $178.7 | 6,276 (Direct) | View |
| 2022-12-06 Option Award | 2022-12-08 4:45 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Washington A. Eugene Director | 351 | $178.7 | 28,163 (Direct) | View |
| 2022-12-06 Option Award | 2022-12-08 4:45 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 240 | $178.7 | 6,152 (Direct) | View |
| 2022-11-30 Exercise | 2022-12-02 4:32 pm | 2016-01-17 2023-01-13 | JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech | 73,323 | $0 | 44,808 (Direct) | View |
| 2022-11-30 Exercise | 2022-12-02 4:32 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech | 73,323 | $72.54 | 44,808 (Direct) | View |
| 2022-11-22 Exercise | 2022-11-23 4:44 pm | 2016-01-17 2023-01-13 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | 76,923 | $0 | 126,456 (Direct) | View |
| 2022-11-22 Exercise | 2022-11-23 4:44 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | 76,923 | $72.54 | 126,456 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-21 4:33 pm | 2017-02-11 2024-02-09 | JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO | 16,928 | $0 | 16,178 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-21 4:33 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO | 16,928 | $90.44 | 16,178 (Direct) | View |
Ownership | 2022-11-14 2:44 pm | N/A N/A | MeiraGTx Holdings plc | MGTX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 0 | $0 | 6,641,064 (Indirect) | View |
| 2022-11-09 Exercise | 2022-11-10 4:47 pm | 2016-01-17 2023-01-13 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer | 16,410 | $0 | 71,644 (Direct) | View |
| 2022-11-09 Exercise | 2022-11-10 4:47 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer | 16,410 | $72.54 | 71,644 (Direct) | View |
| 2022-11-07 Exercise | 2022-11-09 5:01 pm | 2020-02-13 2027-02-13 | JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer | 10,033 | $115.67 | 57,176 (Direct) | View |
| 2022-11-07 Exercise | 2022-11-09 5:01 pm | 2019-02-09 2026-02-08 | JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer | 7,010 | $101.87 | 57,176 (Direct) | View |